Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-18

Clinical Trial Update: Study of Droxidopa Treatment in Adults With Attention Deficit Hyperactivity Disorder With Co-administration of Carbidopa [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating droxidopa with carbidopa for adults with ADHD; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbidopa (Carbidopa)
  • Droxidopa (Droxidopa)

Snippet

Sponsor: Chelsea Therapeutics | Conditions: Attention Deficit Hyperactivity Disorder | Phase 2 | Status: COMPLETED | Results posted: 2024-04-18